{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:31:06Z","timestamp":1776882666341,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T00:00:00Z","timestamp":1500681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ijid.2017.07.019","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T10:46:58Z","timestamp":1501930018000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence"],"prefix":"10.1016","volume":"63","author":[{"given":"Rachel","family":"Bartash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2017.07.019_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijid.2017.01.019","article-title":"Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study","volume":"57","author":"Arshad","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"15","key":"10.1016\/j.ijid.2017.07.019_bib0010","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/dku322","article-title":"Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia","volume":"70","author":"Barber","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"19","key":"10.1016\/j.ijid.2017.07.019_bib0020","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","author":"Blot","year":"2002","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ijid.2017.07.019_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/318717","article-title":"Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia","volume":"32","author":"Caballero-Granado","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.ijid.2017.07.019_bib0035","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.47.9.3002-3004.2003","article-title":"Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"47","author":"Chiang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2017.07.019_bib0040","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","article-title":"Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin","volume":"43","author":"Climo","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2017.07.019_bib0045","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of Vancomycin and beta-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2017.07.019_bib0060","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.clinthera.2014.09.005","article-title":"Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia","volume":"36","author":"Dhand","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.01204-13","article-title":"beta-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0070","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/AAC.44.5.1394-1396.2000","article-title":"Vancomycin and oxacillin synergy for methicillin-resistant staphylococci","volume":"44","author":"Domaracki","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2017.07.019_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2334-7-111","article-title":"In vitro evaluation of antibiotics\u2019 combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections","volume":"7","author":"Drago","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0080","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jac\/dkg440","article-title":"Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis","volume":"52","author":"Drinkovic","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.ijid.2017.07.019_bib0090","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1473-3099(14)70904-1","article-title":"How deadly is meticillin-resistant Staphylococcus aureus?","volume":"14","author":"F\u00e4tkenheuer","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2017.07.019_bib0095","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis","volume":"56","author":"Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2017.07.019_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.43.3.639","article-title":"Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides","volume":"43","author":"Gavald\u00e1","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/jac\/dkg360","article-title":"Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides","volume":"52","author":"Gavald\u00e1","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2017.07.019_bib0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"146","author":"Gavald\u00e1","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/clinids\/15.1.49","article-title":"Nosocomial bacteremia due to Enterococcus faecalis without endocarditis","volume":"15","author":"Graninger","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0195-6701(94)90125-2","article-title":"Enterococcal bacteraemia: a prospective study of 125 episodes","volume":"27","author":"Gray","year":"1994","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clinthera.2016.12.005","article-title":"Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series","volume":"39","author":"Gritsenko","year":"2017","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.ijid.2017.07.019_bib0135","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1128\/AAC.05077-14","article-title":"In vitro activity of daptomycin in combination with beta-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci","volume":"59","author":"Hindler","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0140","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2017.07.019_bib0150","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10156-005-0402-2","article-title":"Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan","volume":"11","author":"Kobayashi","year":"2005","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0160","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jac\/dks453","article-title":"Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus","volume":"68","author":"Leonard","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2017.07.019_bib0165","doi-asserted-by":"crossref","first-page":"e42103","DOI":"10.1371\/journal.pone.0042103","article-title":"Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"7","author":"Leonard","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0170","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2017.07.019_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00005792-198807000-00005","article-title":"Enterococcal bacteremia: clinical features, the risk of endocarditis, and management","volume":"67","author":"Maki","year":"1988","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.1970.00310020064005","article-title":"Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center","volume":"125","author":"Mandell","year":"1970","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.ijid.2017.07.019_bib0190","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"beta-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0195","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2017.07.019_bib0205","article-title":"Antibiotic combinations with daptomycin for treatment of Staphylococcus aureus infections","volume":"2011","author":"Nadrah","year":"2011","journal-title":"Chemother Res Pract"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/338233","article-title":"Swedish Society of Infectious Diseases Quality Assurance Study Group for E. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?","volume":"34","author":"Olaison","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3\u20135","key":"10.1016\/j.ijid.2017.07.019_bib0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drup.2013.10.002","article-title":"Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \u201cseesaw effect\u201d: Taking advantage of the back door left open?","volume":"16","author":"Ortwine","year":"2013","journal-title":"Drug Resist Updat"},{"issue":"5","key":"10.1016\/j.ijid.2017.07.019_bib0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2013.07.005","article-title":"Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature","volume":"42","author":"Polenakovik","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.ijid.2017.07.019_bib0225","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/AAC.48.8.2871-2875.2004","article-title":"Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus","volume":"48","author":"Rand","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkh104","article-title":"Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci","volume":"53","author":"Rand","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0235","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9343(51)90273-2","article-title":"Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin","volume":"10","author":"Robbins","year":"1951","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0240","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2017.07.019_bib0245","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/AAC.02481-12","article-title":"Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline","volume":"57","author":"Sakoulas","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijid.2017.07.019_bib0250","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0255","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.02274-13","article-title":"Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium","volume":"58","author":"Sakoulas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.ijid.2017.07.019_bib0260","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/AAC.01192-16","article-title":"Cefazolin and Ertapenem: A Synergistic Combination Used to Clear Persistent Staphylococcus aureus Bacteremia","volume":"60","author":"Sakoulas","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2017.07.019_bib0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/dkf182","article-title":"Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases","volume":"50","author":"Sandoe","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2017.07.019_bib0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/mdr.1999.5.253","article-title":"Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus","volume":"5","author":"Sieradzki","year":"1999","journal-title":"Microb Drug Resist"},{"issue":"6","key":"10.1016\/j.ijid.2017.07.019_bib0275","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jac\/dkv007","article-title":"beta-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium","volume":"70","author":"Smith","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2017.07.019_bib0285","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13063-016-1295-3","article-title":"CAMERA2 \u2013 combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial","volume":"17","author":"Tong","year":"2016","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.ijid.2017.07.019_bib0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2005.08.014","article-title":"Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin","volume":"54","author":"Tsuji","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2017.07.019_bib0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000441-197703000-00002","article-title":"Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin","volume":"273","author":"Watanakunakorn","year":"1977","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.ijid.2017.07.019_bib0300","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.1973.03220090050011","article-title":"Penicillin and gentamicin therapy for enterococcal infections","volume":"223","author":"Weinstein","year":"1973","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.ijid.2017.07.019_bib0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2017.07.019_bib0310","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00487-10","article-title":"Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the \u201cseesaw effect\u201d)","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijid.2017.07.019_bib0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(14)70876-X","article-title":"A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study","volume":"14","author":"Yaw","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217301984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217301984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T20:46:57Z","timestamp":1659300417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217301984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":63,"alternative-id":["S1201971217301984"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.07.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}